Cancer-control outcomes with [177Lu]Lu-PSMA Radioligand Therapy in elderly, frail or comorbid mCRPC patients. - Wenzel M; Siech C; Garcia CC; Humke C; Groener D; Kriegmair M; Graefen M; Maurer T; Salomon G; Banek S; Chun FKH; Mandel P (Theranostics, 2025)